In humans, brain oscillations are thought to support critical features of memory formation such as coordination of activity across regions, consolidation, and temporal ordering of events. However, understanding the molecular mechanisms underlining this activity in humans remains a major challenge. Here, we measured memory-sensitive oscillations using direct intracranial electroencephalography recordings from the temporal cortex of patients performing an episodic memory task. By then employing transcriptomics on the resected tissue from the same patients, we linked gene expression with brain oscillations, identifying genes correlated with oscillatory signatures of memory formation across six frequency bands. A co-expression analysis isolated biomarker-specific modules associated with neuropsychiatric disorders as well as ion channel activity. Using singlenuclei transcriptomic data from this resected tissue, we further revealed that biomarkerspecific modules are enriched for both excitatory and inhibitory neurons. This unprecedented dataset of patient-specific brain oscillations coupled to genomics unlocks new insights into the genetic mechanisms that support memory encoding. By linking brain expression of these genes to oscillatory patterns, our data help overcome limitations of phenotypic methods to uncover genetic links to memory performance.
Introduction
Genome-wide association studies and gene expression profiling of the human brain have unlocked the ability to investigate the genetic basis of complex brain phenomena. To date, these datasets have principally been applied to non-invasive imaging studies especially correlations with structural MRI or resting state fMRI1-5. Existing methods have relied on published datasets of gene expression from post-mortem brains, meaning that neurophysiological and behavioral data did not come from the same individuals contributing gene expression data6-8. This limits the potential impact of such approaches to uncover insights into how genes support key cognitive processes such as episodic memory and highlights the need to develop new datasets in which individuals contribute both neurophysiological and gene expression data9-11. Another issue in previous studies is that neurophysiological measurements such as resting state fMRI are not directly linked to cognitive phenomenon. With this in mind, we previously attempted to correlate gene expression levels with oscillatory biomarkers of successful memory encoding12, as the fundamental role of these oscillations in supporting memory behavior has been wellestablished in rodent models and human investigations13,14. These biomarkers are measures of the degree to which memory encoding success modulates oscillatory power in a given frequency band. They were quantified using intracranial electrodes implanted for seizure mapping purposes, with recordings made as participants perform an episodic memory task. In this previous analysis, we used a large database of intracranial EEG (iEEG) recordings obtained over 10 years in order to piece together a distribution of these biomarkers across brain regions. The resulting set of genes that we identified that were correlated with these biomarkers included genes with previously established links to memory formation tested in rodent investigations, genes linked to cognitive disorders such as autism, and novel genes that are prime targets for further investigation. However, as with other studies, this dataset did not have the benefit of both neurophysiological and gene expression information from the same individuals.
With the goal of explicating how gene expression gives rise to brain oscillations and identifying propitious targets for neuromodulation to treat memory disorders, here, we compiled an unprecedented dataset of 16 human subjects who first underwent iEEG during which we measured biomarkers of episodic memory encoding using a well refined signal processing pipeline. These subjects then underwent a temporal lobectomy, during which an en bloc resection of the lateral temporal lobe permitted the acquisition of high quality tissue specimens that were processed immediately upon removal from a common brain region from which in vivo recordings had been previously obtained. These tissue specimens were pathologically normal and we excluded individuals in whom seizure onset included this region.
We made the a priori decision to focus on Brodmann area 38 (BA38) in this analysis for the following reasons: 1) the region has been shown to exhibit strong memory related oscillatory biomarkers in multiple investigations15, 16 ; 2) resection of this region is standardized in an en bloc temporal lobectomy operation, allowing the preservation of blood supply to the region until the moment of excision and ensuring a high quality tissue specimen with preservation of cortical architecture for a large sample of tissue; and 3) intracranial EEG investigations preceding temporal lobectomy in this patient population invariably include sampling from this region. Our analysis also offers two additional innovations relative to previous experiments. One is the integration of single nuclei gene expression and chromatin state data using droplet-based microfluidics from surgical human brain samples. Further, we were able to test the cell type-specific expression patterns of genes identified in our analysis as correlated with oscillatory biomarkers using immunofluorescence staining of the related protein products in independent samples, adding confidence to the cell type specificity of the specific genes highlighted.
An inevitable feature of our data set was that all subjects suffered from intractable epilepsy, which presents an important caveat to the interpretations of the results.
However, since we examined gene/biomarker correlations across these individuals rather than in comparison to some alternative cohort of data, we were able to institute control methodologies partially accounting for this concern. These included strict artifact rejection routines and the exclusion of data from regions of seizure onset, as well as using matched post-mortem gene expression samples from both unaffected individuals and persons with epilepsy. We explicitly describe these approaches in the Methods and Results.
Results

Generation of a within-subjects memory biomarker and gene expression dataset
To determine the relationship between memory-related brain oscillations and gene expression, we analyzed iEEG recorded as subjects encoded episodic memories and gene expression data from the same 16 individuals (see Supplementary Table 1 ).
Biomarkers of successful memory encoding (subsequent memory effects or SMEs), were calculated from recorded iEEG signal by comparing oscillatory patterns during successful versus unsuccessful memory encoding. We used the free recall task, a standard test of episodic memory for which oscillatory patterns have been well-described17, and calculated oscillatory biomarkers utilizing our well-established signal processing pipeline12,18,19 ( Fig. 1a and see Methods). Behavioral performance is detailed in Fig. 1 .
On average, subjects remembered 24.3% of memory items, with a rate of list intrusion of 5.4%. These characteristics are consistent with previous publications of the performance of intracranial EEG subjects on this task15. SMEs were extracted from electrodes located in the temporal pole by first normalizing the iEEG signal following wavelet decomposition and statistically comparing oscillatory values between successful versus unsuccessful encoding events across 56 log spaced frequencies from 2 to 120 Hz. The resulting biomarkers were collapsed into six predefined frequency bands prior to entering these data into our model to estimate gene correlation values ( Fig. 1b and see Supplementary Fig. 1a ). We observed evidence of SMEs across the frequency spectrum consistent with a priori expectation, especially in the gamma frequency range. These 16 subjects then underwent a temporal lobectomy operation. This surgery was performed by a single surgeon (BL) using a technique that was standardized across these patients for obtaining tissue from the anterior temporal pole (BA38) ( Fig. 1c ). None of the individuals included in the study had gross or radiographic lesions such as temporal sclerosis or cortical dysplasia. Subjects with seizure onset in the temporal pole were excluded.
We generated whole transcriptome RNA-sequencing (RNA-seq) data from the 16 BA38 samples. In addition to the 16 individuals with matched biomarker measurements and gene expression, we generated BA38 RNA-seq data from an additional 11 temporal lobectomies from patients for whom we did not obtain oscillation measurements, and post-mortem tissue from 12 healthy individuals and 8 epileptic patients in order to crossvalidate our predictions ( Fig. 1d and see Methods). These cross-validated data were used to generate within-subjects correlations of memory biomarker-related brain oscillations and gene expression ( Fig. 1d ). Principal component analysis revealed that gene expression was uniform across samples with no outliers (see Supplementary Fig. 1b ,c).
Variance explained by technical and biological covariates was minimal (see Supplementary Fig. 1d ) and was removed prior to further analyses. These adjusted gene expression values were then used to calculate gene/biomarker correlations across individuals for each frequency band.
Memory biomarkers are correlated with gene expression
To determine the relationship between memory biomarkers and gene expression, we used a Spearman's rank correlation that included the aforementioned cross-validations (see Methods). With this model we identified genes whose expression was correlated with biomarkers in each of the six frequency bands (SME genes). Consistent with a priori expectations, we observed significantly correlated genes across the frequency spectrum, with the largest fraction occurring in the gamma ranges (high and low gamma taken together) ( Fig. 2a ). In line with our previous work12, we confirmed beta oscillations as one of the major contributors to gene correlations (n = 769, P < 0.05, Spearman's rank correlation; see Methods and Supplementary Table 2) . Surprisingly, we found that delta oscillations showed the greatest number of correlated genes (n = 940, P < 0.05, Spearman's rank correlation) ( Fig. 2a and see Supplementary Fig. 2a ). To ensure that these observations were specific for a within-subjects study, we used a cross-validation method by repeating the same correlative analysis randomly subsampling from the additional resected and post-mortem brains (see Methods). On average less than 10% of the observed SME genes were identified in the permutations confirming that correlative analysis is largely disrupted when brain oscillations and gene expression are not matched at the same subject level. This result reflects the importance of a within-subject approach to provide a precise association between cognitive recordings and genomics ( Fig. 2b ; see Supplementary Fig. 2b ). Moreover, consistent with our previous results, we noted that there was a substantial sharing of memory biomarker genes across oscillations ( Fig. 2c ).
We found a significant overrepresentation of beta genes in high gamma genes (Fisher's exact test, FDR corrected, p = 1.0x10-20, OR = 4.58; see Supplementary Fig. 2c ). Delta genes were strongly overrepresented in low gamma genes (Fisher's exact test, FDR corrected, p = 5.0x10-204, OR = 19.3) and in the low-frequency oscillations alpha and theta (Fisher's exact test, FDR corrected, p = 1.0x10-25, OR = 9.42 and p = 4.0x10-86, OR = 18.7, respectively; see Supplementary Fig. 2c ). This pattern specifically suggests that the association of high-frequency power increases and low frequency desynchronization observed across a number of cognitive tasks (but specifically in episodic memory paradigms) may have a common basis in gene expression20,21. Data from these 16 individuals also included a control behavioral paradigm in which individuals perform simple mathematical problems, allowing us to observe oscillatory biomarkers linked to this separate cognitive domain (see Methods). We were therefore able to perform the same analysis as above, with the goal of testing whether biomarker-gene correlations were specific for mnemonic processing. Our data set also included cortical thickness estimates for BA38 for each patient extracted from our FreeSurfer22 processing routine, allowing us to perform an additional control analysis looking for genes correlated with this measurement. Finally, we looked for gene correlations with memory performance (i.e. behavioral data without regard to any oscillatory biomarker observations). Only a limited number of genes correlated with oscillatory biomarkers overlapped with those identified in these control analyses, reinforcing the unique memory-relevant information obtained by examining gene biomarker correlations ( Fig. 2c and see Supplementary Fig. 2d ).
Genes linked to high gamma oscillations showed the most overlap with math-related genes, which may be consistent with a more general cognitive role for genes linked with high gamma oscillations in this brain region but a more memory-specific role for low gamma and delta correlated genes that did not share enrichment for the math correlated genes.
Networks refine molecular pathways associated with memory
We sought to understand the functional properties of the genes identified as correlated with oscillatory biomarkers of successful memory encoding. We performed consensus weighted gene co-expression network analysis (consWGCNA23; see Methods and Supplementary Table 3 ) using gene expression from resected temporal lobe tissue together with the post-mortem gene expression datasets. Using this method, we placed the memory genes into a system-level context identifying co-expression networks (e.g. modules of highly correlated genes) linked with brain oscillations to further prioritize genes. We required that identified modules were robust across these multiple expression data sets (see Methods), identifying 26 total modules. Of these, six were significantly associated with biomarker genes ( Fig. 3a and see Supplementary Fig. 3b ). Two modules were significantly associated with delta oscillations, one module with both delta and low gamma oscillations, and three modules were significantly associated with beta oscillations (Fig. 3a) . Notably, we did not detect module association for genes correlated with cortical thickness or recall fraction whereas genes correlated with oscillations during math tasks were associated with an independent module, further confirming that genes associated with memory encoding and their networks are distinct ( Fig. 3b ). In addition, in three of these modules (WM11, WM12, and WM21), biomarker genes showed higher connectivity compared with the other genes suggesting a central role of these genes in the transcriptome of BA38 ( Supplementary Fig. S3c ). We also observed convergence of genes and modules associated with biomarker genes from our previous work examining gene/biomarker associations across cortical regions12 (Fig. 3c ). The convergence of these findings using different patient populations and methods gives confidence to our inferences regarding the link between these genes and mnemonic processes. The two modules positively associated with delta oscillations (WM4 and WM12 respectively) are enriched for genes implicated in ion channel activity ( Fig. 3d ). Notably, WM4 contains previously identified memory biomarker genes (Fisher's exact test, FDR corrected; p = 0.003, OR = 4.4) whereas WM12 is enriched for a previously identified synaptic related biomarker module (Fisher's exact test, FDR corrected; p = 1.0x10-07, OR = 4.1) ( Fig. 3c ).
CACNA1C, one of the hubs of WM12, encodes for a voltage-gated calcium channel associated with risk for schizophrenia, bipolar disorder, major depression disorder and autism24,25. Furthermore, CACNA1C has been widely implicated in memory processes and memory retrieval24-26. Another WM12 hub is SHANK2, a gene encoding a synaptic scaffolding gene. Mutations in SHANK2 have been linked with autism spectrum disorders, intellectual disability and schizophrenia27-31. Moreover, SHANK2 has been associated with learning and memory deficits32, further confirming the pivotal role of this WM12 hub gene in memory encoding. Importantly, modules associated with different oscillatory frequency bands exhibited different functional properties. Different than the delta associated modules, modules links to beta oscillations (WM11 and WM22) were significantly associated with alternative splicing and chromatin remodeling ( Fig. 3d ). In accordance with previous results12, we observed that both modules are enriched for genes in SME15, a module linked to beta oscillations with genes implicated in splicing (Fisher's exact test, FDR corrected; p = 2.2x10-10, OR = 3.9 and p = 2.1x10-05, OR = 3.8 respectively) ( Fig. 3c ). These data may support alternative splicing regulation as a mechanism for variation in biomarkers observed across individuals. Interestingly, ATRX, one of the hub genes of WM11, is important for cognitive development and it is associated with intellectual disability and memory deficits33,34, further supporting the association between chromatin remodeling and alternative splicing with memory35-37.
Modules of memory biomarkers are linked with neuropsychiatric disorders
We next investigated the association of SME modules with genomic data from brain disorders. Using comprehensive transcriptomic and genetic data from multiple disorders (see Methods), we assessed enrichment for genes dysregulated in neuropsychiatric disorders38 and GWAS enrichment using LD score regression39. The delta associated module WM4 was significantly enriched for down-regulated genes in autism spectrum disorder (ASD; Fisher's exact test, FDR corrected, p = 4.3x10-4, OR = 2.95) and variants associated with ASD (Fisher's exact test, FDR corrected, p = 0.001) ( Fig. 4a ,b and see Supplementary Table 4 ). WM12 showed enrichment for GWAS associated with attention deficit hyperactivity disorder (ADHD; FDR = 0.001), bipolar disorder (BD; FDR = 0.003), major depressive disorder (MDD; FDR = 0.006), schizophrenia (SCZ_2018; FDR = 5.8x10-6) and variants associated with educational attainment (FDR = 0.03) and
intelligence (FDR = 0.002) ( Fig. 4a ,b and see Supplementary Table 4 ). Notably, we found minimal enrichment with variants associated with non-brain related traits and disorders ( Supplementary Fig. 4a ). We next compared the SME modules with those found in a meta-analysis of transcriptomic data across neuropsychiatric disorders38. Both WM4 and WM12 are enriched for a module severely affected in ASD with RBFOX1 as a predominant hub (geneM1; p = 1.5x10-29, OR = 7.9 and p = 2.0x10-10, OR = 3.92 respectively; Supplementary Fig. 4b ). Interestingly, RBFOX1 is also a hub in WM12, further supporting the role of this gene in neuropsychiatric disorders and memory. The beta module WM11 is enriched for schizophrenia variants (SCZ_2018; FDR = 0.03) ( Fig.   4a ,b and see Supplementary Table 4 ) whereas the beta module WM22 is enriched for a splicing module affected in SCZ (geneM19; p = 2.6x10-09, OR = 6.6; see Supplementary   Fig. 4b ). Overall, the association of delta and beta modules with neuropsychiatric disorders where memory is impaired provide further support to the role of these genes and pathways in episodic memory40-43.
Modules of memory biomarkers are associated with specific cell-types
To develop cell-type specific associations for the identified correlated genes, we next performed single nuclei RNA-seq (snRNA-seq) analysis on the tissue from three of the original 16 subjects (see Supplementary Table 1 ). After stringent quality control, expression dimensionality was reduced with principal component analysis (see Methods), and we identified a robust set of 15 transcriptionally-defined clusters (Fig. 5a ). To provide confidence to our analysis, we confirmed our clusters with signatures from a previously published snRNA-seq data from the medial temporal gyri44 (see Methods and Supplementary Fig. 5a ). We defined four inhibitory neuron, eight excitatory neuron and three major non-neuronal clusters. These clusters showed high expression of known major markers for their respective cell types ( Fig. 5b and see Supplementary Table 5 ).
We found that the delta modules WM4 and WM12 are strongly enriched for excitatory and inhibitory neurons ( Fig. 5c ). Interestingly, the module negatively associated with delta, WM21, was enriched for glia cells, with a predominance of oligodendrocyte-related genes ( Fig. 5c ). Using snRNA-seq from ASD and Alzheimer's patients45,46, we found that WM4 is significantly enriched for genes dysregulated in Layer 2/3 excitatory neurons in ASD whereas WM21 is significantly enriched for oligodendrocytes markers affected in Alzheimer's patients ( Supplementary Fig. 5b ,c). These results further confirm the role of the modules associated with delta oscillations in neuropsychiatric disease at single cell level. WM4 and WM12 are both enriched for delta biomarkers, cognitive-disease related variants, and multiple neuronal types. To further validate our approach for the purpose of future memory neuromodulation strategies specific to brain disorders and cell types, we selected one hub gene from each module for further study. IL1RAPL2, an interleukin (IL)-1 receptor accessory protein, is a hub gene in the WM4 module. Intriguingly, along with its paralog IL1RAPL1, IL1RAPL2 promotes functional excitatory synapse and dendritic spine formation47,48 and it is associated with ASD49. Our single nuclei RNA-seq data showed IL1RAPL2 has the greatest expression in excitatory neurons but is also expressed in a subset of inhibitory neurons ( Fig. 5d ). Using fluorescent immunohistochemistry from independently obtained tissue resections, we found that IL1RAPL2 has the greatest overlapping expression with a marker of excitatory neurons, CAMKII, some overlap with a marker of inhibitory neurons, GAD67, and no overlap with a marker of astrocytes, GFAP or a marker of oligodendrocytes, OLIG2 (Fig. 5e,f) . Along with the role in excitatory synapse formation, the snRNA-seq and memory biomarkers association indicated that IL1RAPL2 might play an essential role in regulation of memory encoding in humans. Taken together, these results underscore the importance of further studies focused on the role of IL1RAPL2 in memory and excitatoryinhibitory synaptic etiologies.
Single-nuclei ATAC-seq reveals transcription factors as key regulators of memory-
modules.
We next sought to understand what transcription factors (TFs) regulate modules of memory biomarkers. To this end, we performed single nuclei ATAC-seq (snATAC-seq) analysis on the tissue from one independent subject (see Supplementary Table 1 ). After stringent quality controls, we annotated the snATAC-seq clusters using the snRNA-seq ( Fig. 6a ; see Methods). This multi-omics method allowed us to detect cell-type specific regulatory loci whose accessibility profiles were consistent with the cell-type gene expression. Using motif analysis, we explored the TFs enrichment in the cell-type specific regulatory loci associated with the identified modules of memory biomarkers. Among the modules with cell-type association, motif enrichment was detected only in WM4 and WM12 whereas we did not observe significant enrichment on the oligodendrocytesspecific WM21 (Fig. 6b ; see Supplementary table 6) . Interestingly, we observed that WM4 genes are highly enriched for Mef2-family motifs, with MEF2A as the highest-scoring motif. MEF2A exhibited enrichment in peaks close to the promoter region of several WM4hubs suggesting that MEF2A may play a role in the regulation of these memory-linked genes (see Supplementary Fig. 6 ). Despite the fact that MEF2A showed binding site enrichment, it was not co-expressed with the genes in WM4. We next highlighted the transcription factors that regulate genes in WM12. Interestingly, we found WM12 showed enrichment in motifs of SMAD3, a WM12-hub ( Fig. 6b ; see Supplementary table 6 ). Most remarkably, SMAD3 motifs were observed in the promoter region of WM12-hubs associated with neuropsychiatric disorders and memory such as CACNA1C24-26, SHANK227-31, and NEDD4L50-52 (Fig. 6c ). Related to this, previous work has identified NEDD4L as a modulator of SMAD3 turnover during TGFβ signaling transduction53,54.
TGFβ signaling plays an important role in modulating neural circuits, axonal formation, synaptic plasticity and cognitive bahaviors55-58. Together, the binding site enrichment and co-expression with WM12 hub genes such as NEDD4L indicate the pivotal role of SMAD3 in regulating genes associated with memory oscillations and neuropsychiatric disorders where memory is severely affected. In addition, WM12 contains genes associated with neuronal etiologies, and we found that SMAD3 is specifically expressed in excitatory neurons (Fig. 6d ). This result was further confirmed using fluorescent immunohistochemistry from independently obtained tissue resections (Fig. 6e,f) . Overall, these results highlight the role of specific transcription factors in the regulation of chromatin landscape necessary to express putative genes associated with memory biomarkers and provide novel molecular entry points for understanding human memory.
Discussion
We set out to understand the genomic underpinnings of brain oscillations that support episodic memory encoding in humans, with the ultimate goal of identifying genes that are propitious targets for neuromodulation strategies to treat memory disorders. Using an unparalleled data set of 16 human subjects from which we obtained measurements of brain oscillations linked to successful episodic memory encoding as well as whole transcriptomic data from the temporal pole in the same individuals, we identified modules of genes that link specific cell types and cellular functions with memory biomarkers. One point worthy of emphasis is that our analysis is fundamentally different than previous attempts to correlate gene expression with behavioral measurements such as memory performance59-61. Oscillatory correlates of successful memory encoding represent an "intermediate step" between gene regulation and memory behavior. Oscillations are localized to the brain region in which they are recorded using intracranial depth electrodes and are dissociable into frequency bands with distinct properties. Linking neurophysiological measurements (such as these oscillatory biomarkers) with gene expression data will establish specific testable hypotheses for subsequent investigations for these genes we have identified. Our work sheds light on the molecular mechanisms that give rise to oscillatory correlates of successful memory encoding62. In this regard, our observation that delta oscillations are linked to ion channel genes and further that these genes tend to be expressed in oligodendrocytes leads to the fascinating implication that the generation of low-frequency oscillatory patterns linked to mnemonic processing in humans is at least partially dependent upon glial modulation of oscillations. This is based upon a combination of our observations across all subjects as well as the single nuclei expression analysis. This conclusion is supported by the role of oligodendrocytes in learning and memory acting on depolarization of membrane potential63-66, which accelerates axonal conduction and ion channel activity as reflected by the delta modules with positive association (WM4 and WM12). We note that we observed interesting properties for genes correlated with delta oscillations, but not theta oscillations which prima fascia runs contrary to rodent data that universally implicate theta frequency activity in successful memory formation67. However, in the human temporal lobe, oscillations outside of the 4-9 Hz range routinely exhibit memory-relevant properties, including cross-frequency coupling, and as such our findings are in line with previous observations using biomarkers of successful memory encoding in humans68,69. In humans these low frequency oscillations represent a consistent feature of oscillatory signatures of memory formation, including influence on the timing of single unit activity68,70-72. The significant representation of delta correlated genes in our analysis may reflect the functional importance of these low frequency components in humans. One necessary caveat in interpreting our data is the fact that all subjects suffer from intractable epilepsy. Clearly, the use of such a subject population is necessary to generate these highly valuable data with both in vivo oscillations and gene expression data from the same individuals in humans. However, several features of our analysis such as under-enrichment for genetic variants associated with epilepsy and the data integration with epileptic and healthy tissues give us confidence that the insights we have uncovered represent more generalizable associations between gene expression and brain oscillations. Further, numerous human studies have established that observations in iEEG patients have correlates using noninvasive studies in normal control individuals and in animal models73- 76 . Additionally, we employed strict artifact rejection criteria and eliminated electrodes located in the seizure onset zone in our analysis, reducing the impact of abnormal activity on observed oscillatory biomarkers76,77. We also included several control steps in our analysis including incorporation of duration of epilepsy to adjust gene expression values.
Finally, several of the key genes we have identified (for example CACNA1C, MET, and SMAD3) have been independently shown to be linked to memory processing in data from non-epileptic individuals. Collectively, this translational work establishes an experimental and analytical approach for deconstructing human behavioral and cognitive traits such as memory using integrative physiological and multi-omics techniques.
Integration of single nucleus transcriptomic and epigenomic data allowed us to identify the cell type specificity of the memory-related gene co-expression modules as well as potential regulators of these modules (e.g. SMAD3and MEF2A). For example, our data suggest that SMAD3 acts as a regulator of genes and molecular pathways involved in memory encoding-related delta oscillations, specifically in excitatory neurons. This molecular characterization of human memory highlights a key regulator that can be further studied in model systems. We anticipate that this within-subjects approach can be used in future studies to highlight molecular pathways of other human complex traits with the ultimate goal of identifying therapeutic targets and linking clinical and genomic data at the individual subject level. Importantly, investigations using animal and in vitro models will be necessary to definitively characterize the memory related properties of the genes identified in our analysis.
Methods
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Resected brain samples
All surgical samples included in this study were BA38 resections from patients with temporal lobe epilepsy. The brain specimen was dropped into ice-cold 1X PBS in a 50mL conical tube immediately after removal from the patient. After 4-5 inversions, the tissue sample was transferred to a fresh tube with ice-cold 1X PBS for a second wash. The specimen was then moved to a petri dish and dissected grossly by scalpel into ~12 subsamples and frozen immediately in individual Eppendorf tubes in liquid nitrogen as the tubes were filled. Care was taken to avoid major blood vessels. Gray matter was prioritized over tracts of white matter in an attempt to increase homogeneity and consistency of results across all samples. Time from removal of brain to flash freezing ranged from roughly two minutes for the first piece to about seven minutes for the last sub-sample. Three to four of the sub-samples were extracted for RNA, and the subsample with the highest RIN value was selected for RNA-sequencing. See Supplementary Table S1 for detailed demographic information.
Postmortem brain samples
Twelve samples of BA38 were obtained from the Dallas Brain Collection. These tissue samples were donated from individuals without a history of neurological or psychiatric disorders as previously published78. Eight samples of BA38 were obtained from the University of Maryland Brain and Tissue Bank. These samples were donated from individuals with epilepsy. See Supplementary Table S1 for detailed demographic information.
RNA-sequencing (RNA-seq)
Total RNA was purified using an miRNeasy kit (#217004, Qiagen) following the manufacturer's recommendations. RNA-seq libraries from mRNA were prepared inhouse as previously described79. Sequencing was performed on randomly pooled samples by the McDermott Sequencing Core at UT Southwestern on an Illumina NextSeq 500 sequencer. Single-end, 75-base-pair (bp) reads were generated.
Isolation of nuclei from resected brain tissues (snRNA-seq)
Nuclei were isolated as previously described80 https://www.protocols.io/view/rapid-nucleiisolation-from-human-brain-scpeavn. Surgically resected cortical tissue was homogenized using a glass dounce homogenizer in 2 ml of ice-cold Nuclei EZ lysis buffer (#EZ PREP NUC-101, Sigma) and was incubated on ice for 5 min. Nuclei were centrifuged at 500 × g for 5 min at 4 °C, washed with 4 ml ice-cold Nuclei EZ lysis buffer and, incubated on ice for 5 min. Nuclei were centrifuged at 500 × g for 5 min at 4 °C. After 
Isolation of nuclei from resected brain tissue (snATAC-seq)
For snATAC-seq, nuclei were isolated as described above. After lysis, the nuclei were 
Immunofluorescence staining of human tissue
Fresh surgically resected tissue was fixed in 4% PFA in 1x PBS 24-48h at 4C and then cryoprotected in a 30% sucrose solution. The tissue was sectioned at 7 µm using a cryostat (Leica). Sections underwent heat induced antigen retrieval in a citrate buffer (pH 
COMPUTATIONAL METHODS
RNA-seq mapping, QC and expression quantification
Reads were aligned to the human hg38 reference genome using STAR 2.5.2b82 with the following parameters: "--outFilterMultimapNmax 10 --alignSJoverhangMin 10 --alignSJDBoverhangMin 1 --outFilterMismatchNmax 3 --twopassMode Basic". For each sample, a BAM file including mapped and unmapped reads that spanned splice junctions was produced. Secondary alignment and multi-mapped reads were further removed using in-house scripts. Only uniquely mapped reads were retained for further analyses. Quality control metrics were performed using RSeQC83 using the hg38 gene model provided.
These steps include: number of reads after multiple-step filtering, ribosomal RNA reads depletion, and defining reads mapped to exons, UTRs, and intronic regions. Picard tool was implemented to refine the QC metrics (http://broadinstitute.github.io/picard/). Gencode annotation for hg38 (version 24) was used as reference alignment annotation and downstream quantification. Gene level expression was calculated using HTseq version 0.9.184 using intersection-strict mode by gene. Counts were calculated based on protein-coding genes from the annotation file.
Covariate adjustment
Counts were normalized using counts per million reads (CPM) with edgeR package in R 85. Normalized data were log2 scaled with an offset of 1. Genes with no reads were removed. Normalized data were assessed for effects from known biological covariates (Sex, Age, Race, Ethnicity, Hemisphere, Epilepsy Duration), technical variables related to sample processing (RNA integrity number: RIN, Batch). Other biological and technical covariates (Post-mortem interval: PMI) were not considered for the analysis because they were confounded with the brain resected data. The data were adjusted for technical covariates using a linear model:
lm(gene expression ~ Sex + Age + Race + Ethnicity + Hemisphere + Epilepsy Duration + RIN + Batch)
Adjusted CPM values were used for SME correlation, co-expression analysis and visualization.
Correlation analysis and cross-validation analysis
Spearman's rank correlation was performed between each of the 6 memory brain oscillations and gene expression. We also utilized this method for 6 math brain oscillations, thickness and behavioral performances.
For this analysis we used:
1. Within Subject: bulk RNA-seq from Brodmann's area 38 resected tissue of 16 subjects with calculated SME (WrS). We next performed cross-validation analysis using data from:
1. Additional Subjects: additional 11 subjects of bulk RNA-seq from Brodmann's area 38 resected tissue without SME (ArS). 
Independent Data
Independent Data Epilepsy: bulk RNA-seq from Brodmann's area 38 frozen tissue of 8 subjects with Epilepsy (EfS).
Bootstrap was applied randomly sampling 16 subjects (as WrS) from the composite data and recalculating the correlation 100 times. We then calculated a Monte Carlo p-value comparing the observed effect with the simulated effects for each gene by:
sum(abs(simulated rho) >= observed rho)/100
We calculated two Monte Carlo p-values:
BootP based on WrS + ArS (only resected tissues)
BootP_All based on WrS + ArS + HfS + EfS (resected tissues and frozen tissues)
We additionally applied a permutation approach shuffling the gene expression of WS and recalculating 100 times the correlation between oscillations and gene expression. We then calculated a Monte Carlo p-value (PermP). Nominal p.value < 0.05, PermP < 0.05, BootP < 0.05 and BootP_All < 0.05 were used to filter for significant correlations as reported in Table S2 . Finally, we used ArS + HfS + EfS (additional resected tissues and frozen tissues) for the subsampling showed in the Figure 2b and Supplementary Fig. 2b .
Briefly, we subsample from ArS + HfS + EfS 16 random subjects 100 times and performed the correlative analysis. We next selected the number of genes that were significant in each of the 100 shuffle and compared them with the observed SME genes.
Co-expression network analysis
To identify modules of co-expressed genes in the RNA-seq data, we carried out weighted gene co-expression network analysis (WGCNA)23. We applied a consensus analysis based on WrS + ArS + HfS + EfS data defining modules highly preserved across multiple datasets. This method was applied to reduce the potential noise between different types of data. A soft-threshold power was automatically calculated to achieve approximate 
Single-nuclei RNA-seq analysis
Single-nuclei RNA-seq data from BA38 was processed using mkfastq command from 10X
Genomics CellRanger v3.0.1. Extracted paired-end fastq files (26 bp long R1 -cell barcode and UMI sequence information, 124 bp long R2 -transcript sequence information) were checked for read quality using FastQC. Gene counts were obtained by aligning reads to the hg38 genome using an in-house pipeline. UMI-tools86 were used to match barcode and reads. Reads were aligned to the human hg38 reference genome using STAR 2.5.2b82. Gencode annotation for hg38 (version 24) was used as reference alignment annotation. Gene level expression was calculated using featureCounts87 by gene. UMIs were further calculated using UMI-tools. Seurat88 standard pipeline was used for downstream analysis and cell-markers definition (see Code Availability).
Single-nuclei ATAC-seq analysis
Single-nuclei ATAC-seq data from BA38 was processed using Cell Ranger ATAC pipeline (see Code Availability). Seurat extension Signac88 was used for additional filtering, clustering and annotation. Cells with total fragments in peaks less than 1000 or less than 15% of the total fragments were not considered for future analysis. 
Functional Enrichment
The functional annotation of differentially expressed and co-expressed genes was performed using ToppGene92. We used GO and KEGG databases. Pathways containing between 5 and 2000 genes were retained. A Benjamini-Hochberg FDR (P < 0.05) was applied as a multiple comparisons adjustment.
GWAS data and enrichment
Summary statistics for GWAS studies on neuropsychiatric disorders and non-brain disorders were downloaded from Psychiatric Genomics Consortium and GIANT Consortium93-107. MAGMA v1.0439 was used for gene set analysis. Supplementary Table   4 reports MAGMA statistics for each of the GWAS data analyzed. GWAS acronyms were 
Gene set enrichment
Gene set enrichment was applied to correlated genes and SME genes12 from our previous study as shown in Fig. 3c , neuropsychiatric DEGs as shown in Fig. 4a and Supplementary   Fig. 4b , and cell-type markers as shown in Fig. 5c and Supplementary Fig. 5 . We used a
Fisher's exact test in R with the following parameters: alternative = "greater", conf.level = 0.95. We reported Odds Ratios (OR) and Benjamini-Hochberg adjusted P-values (FDR).
Angeles Healthcare Center; and the University of Miami Brain Endowment Bank) and the UT Neuropsychiatry Research Program (Dallas Brain Collection). tissue was integrated with brain oscillation data derived from subsequent memory effect (SME) analysis, identifying protein-coding genes strongly associated with SMEs (SME genes). Cross-validations with additional human BA38 samples from independent sources was performed. SME genes were prioritized using co-expression networks and specified at the cell-type level using snRNA-seq from BA38. specific SME genes between brain oscillations. d, Venn diagram showing shared and specific genes between genes associated with memory effect (SME), genes associated with math task (MATH), genes associated with cortical thickness (Thickness), and genes associated with recalled words (Recall). 
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